Search research articles
Contact Us
Filters
Showing results (131-140 of 141) with videos related to
Page
of 15
Sort By:
Circulation
|
October 12, 2000
Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial
E J Topol, E M Ohman, P W Armstrong, et al.
Diabetologia
|
November 6, 2010
Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
T M E Davis, R Ting, J D Best, et al.
Lancet (London, England)
|
November 9, 2007
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial
A C Keech, P Mitchell, P A Summanen, et al.
British Journal of Cancer
|
September 15, 2011
Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer
C K Lee, R J Simes, C Brown, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 18, 2020
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial
P Grimison, A Mersiades, A Kirby, et al.
British Journal of Cancer
|
December 17, 2013
Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer
D J Jonker, C S Karapetis, C Harbison, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 13, 2012
Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17
M M Vickers, C S Karapetis, D Tu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2020
Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial
A P Barbour, E T Walpole, G T Mai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 30, 2012
A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer
C K Lee, R J Simes, C Brown, et al.
JAMA
|
June 7, 2018
Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration
Lisa M Askie, Brian A Darlow, Neil Finer, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 141) with videos related to
Sort By:
Page
of 15
Circulation
|
October 12, 2000
Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial
E J Topol, E M Ohman, P W Armstrong, et al.
Diabetologia
|
November 6, 2010
Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
T M E Davis, R Ting, J D Best, et al.
Lancet (London, England)
|
November 9, 2007
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial
A C Keech, P Mitchell, P A Summanen, et al.
British Journal of Cancer
|
September 15, 2011
Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer
C K Lee, R J Simes, C Brown, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 18, 2020
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial
P Grimison, A Mersiades, A Kirby, et al.
British Journal of Cancer
|
December 17, 2013
Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer
D J Jonker, C S Karapetis, C Harbison, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 13, 2012
Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17
M M Vickers, C S Karapetis, D Tu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2020
Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial
A P Barbour, E T Walpole, G T Mai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 30, 2012
A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer
C K Lee, R J Simes, C Brown, et al.
JAMA
|
June 7, 2018
Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration
Lisa M Askie, Brian A Darlow, Neil Finer, et al.
Page
of 15